Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

ChampionX Corp C.CHX


Primary Symbol: CHX

ChampionX Corporation is engaged in offering chemistry solutions, artificial lift systems, and engineered equipment and technologies that help companies drill for and produce oil and gas. The Company’s Production Chemical Technologies segment offers products and services that cover a range of onshore, offshore, and oil sands chemical solutions in production and midstream operations. Its Production & Automation Technologies segment offers products, technologies, and services that facilitate the extraction of oil and gas through artificial lift and digital automation applications. It designs, manufactures, markets a full range of artificial lift equipment, end-to-end automation, and digital solutions, and other production equipment and emissions monitoring solutions. Its Drilling Technologies segment offers polycrystalline diamond cutter (PDC) inserts, bearings, valves, and mining tools. Its Reservoir Chemical Technologies segment offers chemistry-oriented solutions and technologies.


NDAQ:CHX - Post by User

Post by hockeytownon May 09, 2017 8:41am
168 Views
Post# 26219921

Great News

Great News

2017-05-08 16:16 ET - News Release

 

Mr. Ash Kaushal reports

CHROMEDX COMPLETES RECEPTOR COMPONENT AND COMMENCES PACKAGING OF HEMOPALM ANALYZER PROTOTYPE

ChroMedX Corp. has completed the cartridge receptor component for the HemoPalm analyzer prototype. The company also announces the engagement of rapid prototyping firm Agile Manufacturing Inc. to complete the final assembly and packaging of the HemoPalm Analyzer prototype.

The receptor is a crucial part of the HemoPalm analyzer responsible for receiving, aligning and activating the measurement process of the cartridge. This was the final component required to complete prototype assembly, and ChroMedX is now working with Agile Manufacturing to package the functional prototype.

"We are very excited to move into the assembly and packaging phase following the completion of the cartridge receptor. Agile's rapid prototyping capabilities make them an ideal partner in this final stage of prototype development," said Ash Kaushal, president and chief executive officer of ChroMedX.

The HemoPalm prototype is now being assembled and packaged conjointly with Canada's largest 3-D printing service company, Agile Manufacturing, of Uxbridge, Ont. Agile is currently refining the assembly of the prototype and designing the housing for the hand-held prototype.

Receptor function

The receptor includes the following components:

 

  • A front opening to receive and align the cartridge and thereby provide electrical contact between the biosensors and the analyzer; 
  • A mechanism for activating the calibration blister and air bladder;
  • A light source to pass through the blood in the optical chamber for measurement in the spectrometer;
  • Heating elements on the surface of the bottom portion of the receptor to preheat the blood;
  • A thermistor for regulating the heaters;
  • A spring-loaded ball mechanism to hold the cartridge against the heaters and to keep it in operational position.

 

The measurement process will start automatically once correct cartridge insertion is detected and will progress through the following steps:

 

  • Optical reading will be performed for the CO-oximeter measurement.
  • The built-in mechanism will activate and rupture the blister, releasing calibration fluid into the biosensor chamber in order to calibrate the sensors.
  • A second built-in mechanism will activate the air bladder, pushing the blood sample into the biosensor chamber. An air bubble created in the cartridge will keep the blood and calibration fluid separate during this stage, with the air bubble assisting in purging the calibration fluid out of the biosensor chamber.
  • With blood now occupying the biosensor chamber, measurements by the biosensors will be performed and results displayed on the HemoPalm LCD.

 

With regard to the foregoing, the company recently announced the filing of second PCT (Patent Cooperation Treaty) application on its patented HemoPalm hand-held blood analyzer, accounting for continued innovations and potentially extending protection on the intellectual property to 2037.

About ChroMedX Corp.

ChroMedX is a medical technology company focused on the development of novel medical devices for in vitro diagnostics and point-of-care testing.

The HemoPalm hand-held blood analyzer system is the only hand-held blood analysis technology which combines blood gases and electrolytes with full CO-oximetry.

We seek Safe Harbor.

 
<< Previous
Bullboard Posts
Next >>